← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 19, 2017Last known activity
Jan 31, 2025
Timeline
2010s
- Jun 1, 2015
CStone Pharmaceuticals— Founded
Drugs by trial phase (21 distinct, 27 trials)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Esophageal Squamous Cell Carcinoma
- Gastrointestinal Stromal Tumors
- Hodgkin Disease
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, T-Cell
- Neoplasms
- Small Cell Lung Carcinoma
Recent trials (32)
- NCT06741644Lead sponsorPhase 1Jan 31, 2025
- NCT05700448Lead sponsorPhase 3Jul 31, 2024
- NCT05700448Study directorPhase 3Jul 31, 2024
- NCT05297890Lead sponsorPhase 2May 27, 2022
- NCT05279300Lead sponsorPhase 1Mar 28, 2022
- NCT04472858CollaboratorPhase 1/Phase 2Jan 31, 2021
- NCT04421352Lead sponsorPhase 1Jun 30, 2020
- NCT04233060Study directorPhase 1Jan 31, 2020
- NCT04233060Lead sponsorPhase 1Jan 31, 2020
- NCT04200404Lead sponsorPhase 1/Phase 2Dec 31, 2019
- NCT04194775Lead sponsorPhase 3Dec 30, 2019
- NCT04194801Lead sponsorPhase 1/Phase 2Dec 30, 2019
- NCT04187352Lead sponsorPhase 3Dec 30, 2019
- NCT04338724Lead sponsorPhase 1Dec 27, 2019
- NCT04162301Lead sponsorPhase 1Nov 12, 2019
Details
- Founded
- Suzhou, CN Jun 1, 2015
- Last known activity
- Jan 31, 2025